Dr. Nina A. Paleologos has joined Rush University Medical Center in the Department of Neurological Sciences, effective Sept. 10. Paleologos comes to Rush from NorthShore University HealthSystem, where she served as the director of neuro-oncology, and the Stanley C. Golder Chair of Neuroscience Research.
“Paleologos is a highly regarded researcher and clinician who is known for her novel treatments for brain tumors. Her work in multiple clinical trials helped lead to the only FDA-approved drug for recurrent glioblastoma multiforme,” said Dr. Jacob Fox, chairperson of neurological sciences and professor, Department of Neurology at Rush.
Paleologos has research interests in primary brain tumors with particular expertise in astrocytoma and oligodendroglioma. Paleologos has authored over 40 articles and more than 35 abstracts in numerous peer-reviewed medical journals; written book chapters on primary brain tumors and metastatic cancer to the nervous system, chemotherapy of oligodendrogliomas, corticosteroids in neuro-oncology, and neurologic complications of chemotherapy and radiation therapy.
Paleologos’ professional society memberships include the American Academy of Neurology, American Neurological Association, Central Society for Neurologic Research, Chicago Neurologic Society, Society for Neuro-Oncology, the Oligodendroglioma Tumor Study Group, the Central NeuroOncology Group, and the Brain Tumor Trial Collaborative.
Read the entire news release.